Taspoglutide, a once-weekly glucagon-like peptide 1 analogue, vs. insulin glargine titrated to target in patients with Type 2 diabetes: an open-label randomized trial

M. Nauck, E. Horton, M. Andjelkovic, F. J. Ampudia-Blasco, C. T. Parusel, M. Boldrin and R. Balena

Diabetic Medicine 30 ( 1 ): 109 - 113 , 2013